FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036696904> ?p ?o ?g. }

• W3036696904 endingPage "e20738" @default.
• W3036696904 startingPage "e20738" @default.
• W3036696904 abstract "There is a discordance in the immunohistochemical markers between primary breast cancer and recurrent or metastatic breast cancer. This study aimed to assess the recent trends and prognostic features in the treatment of recurrent or metastatic breast cancer Overall, 107 patients were identified from January 2001 to August 2018 at the Peking Union Medical College Hospital, Beijing, and People's Republic of China to obtain a cohort of breast carcinoma patients who were confirmed to have recurrent or metastatic breast cancer by histopathology. We evaluated patient and tumor characteristics and examined the relationships between these factors and prognosis. The estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) positivity, and Ki67 index in primary breast cancer were 63.6% (68/107), 58.9% (63/107), 19.8% (21/106) and 75.8% (75/99), respectively, while those in recurrent or metastatic lesions were 60.6% (65/107) (P = .672), 46.7% (50/107) (P = 0.013), 23.8% (25/105) (P = 0.482)and 83.5%(81/97)(P = 0.178), respectively. The discordance rate of HER2 expression was 10.6% (11/104), while that of PR expression was 23.3% (21/90). HER2 was the most stable biomarker. The discordance rates for luminal A and HER2 were as high as 100% and 25%, respectively, while the luminal B and triple negative values were as low as 8.3% and 5.3%, respectively. ER and PR positivity and the Ki-67 index tended to increase due to recurrence or metastases; however, the discordance for PR and Ki-67 was high. PR is more variable than ER in the expression of primary and recurrent or metastatic breast cancer. The expression of HER2 receptor was the most stable and the discordance rate of triple negative breast cancer was the lowest. Therefore, although changes in biomarkers are due to recurrence or metastasis, pathological confirmation and exploration of markers are very important." @default.
• W3036696904 created "2020-06-25" @default.
• W3036696904 creator A5000487659 @default.
• W3036696904 creator A5032123228 @default.
• W3036696904 creator A5067955467 @default.
• W3036696904 creator A5074054433 @default.
• W3036696904 creator A5083494977 @default.
• W3036696904 creator A5090259825 @default.
• W3036696904 date "2020-06-19" @default.
• W3036696904 modified "2023-10-18" @default.
• W3036696904 title "Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer" @default.
• W3036696904 cites W1881198168 @default.
• W3036696904 cites W1976323199 @default.
• W3036696904 cites W2006492098 @default.
• W3036696904 cites W2013822060 @default.
• W3036696904 cites W2024495581 @default.
• W3036696904 cites W2024814482 @default.
• W3036696904 cites W2034707990 @default.
• W3036696904 cites W2044702943 @default.
• W3036696904 cites W2059316622 @default.
• W3036696904 cites W2063874882 @default.
• W3036696904 cites W2108248587 @default.
• W3036696904 cites W2113233663 @default.
• W3036696904 cites W2126324838 @default.
• W3036696904 cites W2135890715 @default.
• W3036696904 cites W2145699015 @default.
• W3036696904 cites W2152940687 @default.
• W3036696904 cites W2165199249 @default.
• W3036696904 cites W2166810107 @default.
• W3036696904 cites W2170813095 @default.
• W3036696904 cites W2235523093 @default.
• W3036696904 cites W2278259569 @default.
• W3036696904 cites W2314556209 @default.
• W3036696904 cites W2468868288 @default.
• W3036696904 cites W2583320890 @default.
• W3036696904 cites W4237111546 @default.
• W3036696904 doi "https://doi.org/10.1097/md.0000000000020738" @default.
• W3036696904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7310874" @default.
• W3036696904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32569215" @default.
• W3036696904 hasPublicationYear "2020" @default.
• W3036696904 type Work @default.
• W3036696904 sameAs 3036696904 @default.
• W3036696904 citedByCount "6" @default.
• W3036696904 countsByYear W30366969042021 @default.
• W3036696904 countsByYear W30366969042022 @default.
• W3036696904 countsByYear W30366969042023 @default.
• W3036696904 crossrefType "journal-article" @default.
• W3036696904 hasAuthorship W3036696904A5000487659 @default.
• W3036696904 hasAuthorship W3036696904A5032123228 @default.
• W3036696904 hasAuthorship W3036696904A5067955467 @default.
• W3036696904 hasAuthorship W3036696904A5074054433 @default.
• W3036696904 hasAuthorship W3036696904A5083494977 @default.
• W3036696904 hasAuthorship W3036696904A5090259825 @default.
• W3036696904 hasBestOaLocation W30366969041 @default.
• W3036696904 hasConcept C121608353 @default.
• W3036696904 hasConcept C126322002 @default.
• W3036696904 hasConcept C142724271 @default.
• W3036696904 hasConcept C143998085 @default.
• W3036696904 hasConcept C185592680 @default.
• W3036696904 hasConcept C204232928 @default.
• W3036696904 hasConcept C2775930923 @default.
• W3036696904 hasConcept C2781197716 @default.
• W3036696904 hasConcept C29456083 @default.
• W3036696904 hasConcept C530470458 @default.
• W3036696904 hasConcept C544855455 @default.
• W3036696904 hasConcept C55493867 @default.
• W3036696904 hasConcept C71924100 @default.
• W3036696904 hasConcept C84606932 @default.
• W3036696904 hasConcept C98717036 @default.
• W3036696904 hasConceptScore W3036696904C121608353 @default.
• W3036696904 hasConceptScore W3036696904C126322002 @default.
• W3036696904 hasConceptScore W3036696904C142724271 @default.
• W3036696904 hasConceptScore W3036696904C143998085 @default.
• W3036696904 hasConceptScore W3036696904C185592680 @default.
• W3036696904 hasConceptScore W3036696904C204232928 @default.
• W3036696904 hasConceptScore W3036696904C2775930923 @default.
• W3036696904 hasConceptScore W3036696904C2781197716 @default.
• W3036696904 hasConceptScore W3036696904C29456083 @default.
• W3036696904 hasConceptScore W3036696904C530470458 @default.
• W3036696904 hasConceptScore W3036696904C544855455 @default.
• W3036696904 hasConceptScore W3036696904C55493867 @default.
• W3036696904 hasConceptScore W3036696904C71924100 @default.
• W3036696904 hasConceptScore W3036696904C84606932 @default.
• W3036696904 hasConceptScore W3036696904C98717036 @default.
• W3036696904 hasIssue "25" @default.
• W3036696904 hasLocation W30366969041 @default.
• W3036696904 hasLocation W30366969042 @default.
• W3036696904 hasLocation W30366969043 @default.
• W3036696904 hasLocation W30366969044 @default.
• W3036696904 hasLocation W30366969045 @default.
• W3036696904 hasOpenAccess W3036696904 @default.
• W3036696904 hasPrimaryLocation W30366969041 @default.
• W3036696904 hasRelatedWork W1970614368 @default.
• W3036696904 hasRelatedWork W2029773517 @default.
• W3036696904 hasRelatedWork W2352033025 @default.
• W3036696904 hasRelatedWork W2516201043 @default.
• W3036696904 hasRelatedWork W2651034595 @default.
• W3036696904 hasRelatedWork W2765336906 @default.

• next